Metabolic and functional relevance of HDL subspecies

被引:160
作者
Asztalos, Bela F. [1 ]
Tani, Mariko [1 ]
Schaefer, Ernst J. [1 ]
机构
[1] Tufts Univ, Human Nutr Res Ctr Aging, Lipid Metab Lab, Boston, MA 02111 USA
关键词
dysfunctional HDL; HDL; HDL function; HDL metabolism; HDL structure; HDL subclass; DENSITY-LIPOPROTEIN CHOLESTEROL; APOLIPOPROTEIN-A-I; CARDIOVASCULAR EVENTS; ENDOTHELIAL LIPASE; ANTIINFLAMMATORY PROPERTIES; SPHINGOSINE; 1-PHOSPHATE; SUBPOPULATION PROFILE; GENETIC-VARIATION; RESIDUAL RISK; PARTICLE-SIZE;
D O I
10.1097/MOL.0b013e3283468061
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purpose of review Our purpose is to review recent findings highlighting the metabolic and functional diversity of HDL subspecies. Recent findings HDL heterogeneity - both structural and functional - is the main focus of this review. Recent work indicates that the metabolism and functionality of HDL particles differ greatly among HDL subspecies. With the introduction of new and improved methodology (e.g., proteomics), new aspects of the structural complexity and functionality of HDL have been revealed. It has been confirmed that HDL functions including, but not limited to decreasing inflammation, apoptosis, macrophage adhesion to the endothelium and insulin resistance - are due to HDL's ability to remove cholesterol from cells (reverse cholesterol transport). A new level of HDL complexity has recently been revealed by investigating the lipid composition of HDL with gas chromatography, gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry. There are about 100 different HDL-associated proteins; however, there are many more lipid species potentially associated with HDL particles. Summary The most important recent findings disclose that HDL is more complex than previously thought. HDL subclasses differ in physical-chemical properties, protein and lipid composition, metabolism, physiological functions and pathophysiological significance. The staggering complexity of HDL demands significantly more investigation before we can truly begin to understand HDL metabolism and function in humans.
引用
收藏
页码:176 / 185
页数:10
相关论文
共 96 条
[1]   A functional ABCA1 gene variant is associated with low HDL-cholesterol levels and shows evidence of positive selection in Native Americans [J].
Acuna-Alonzo, Victor ;
Flores-Dorantes, Teresa ;
Kruit, Janine K. ;
Villarreal-Molina, Teresa ;
Arellano-Campos, Olimpia ;
Huenemeier, Tabita ;
Moreno-Estrada, Andres ;
Guadalupe Ortiz-Lopez, Ma ;
Villamil-Ramirez, Hugo ;
Leon-Mimila, Paola ;
Villalobos-Comparan, Marisela ;
Jacobo-Albavera, Leonor ;
Ramirez-Jimenez, Salvador ;
Sikora, Martin ;
Zhang, Lin-Hua ;
Pape, Terry D. ;
de Angeles Granados-Silvestre, Ma ;
Montufar-Robles, Isela ;
Tito-Alvarez, Ana M. ;
Zurita-Salinas, Camilo ;
Bustos-Arriaga, Jose ;
Cedillo-Barron, Leticia ;
Gomez-Trejo, Celta ;
Barquera-Lozano, Rodrigo ;
Vieira-Filho, Joao P. ;
Granados, Julio ;
Romero-Hidalgo, Sandra ;
Huertas-Vazquez, Adriana ;
Gonzalez-Martin, Antonio ;
Gorostiza, Amaya ;
Bonatto, Sandro L. ;
Rodriguez-Cruz, Maricela ;
Wang, Li ;
Tusie-Luna, Teresa ;
Aguilar-Salinas, Carlos A. ;
Lisker, Ruben ;
Moises, Regina S. ;
Menjivar, Marta ;
Salzano, Francisco M. ;
Knowler, William C. ;
Catira Bortolini, M. ;
Hayden, Michael R. ;
Baier, Leslie J. ;
Canizales-Quinteros, Samuel .
HUMAN MOLECULAR GENETICS, 2010, 19 (14) :2877-2885
[2]   Lipoprotein-specific transport of circulating lipid peroxides [J].
Ahotupa, Markku ;
Suomela, Jukka-Pekka ;
Vuorimaa, Timo ;
Vasankari, Tommi .
ANNALS OF MEDICINE, 2010, 42 (07) :521-529
[3]   Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A2 [J].
Annema, Wijtske ;
Nijstad, Niels ;
Toelle, Markus ;
de Boer, Jan Freark ;
Buijs, Ruben V. C. ;
Heeringa, Peter ;
van der Giet, Markus ;
Tietge, Uwe J. F. .
JOURNAL OF LIPID RESEARCH, 2010, 51 (04) :743-754
[4]   Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment [J].
Ansell, BJ ;
Navab, M ;
Hama, S ;
Kamranpour, N ;
Fonarow, G ;
Hough, G ;
Rahmani, S ;
Mottahedeh, R ;
Dave, R ;
Reddy, ST ;
Fogelman, AM .
CIRCULATION, 2003, 108 (22) :2751-2756
[5]   Relation of gemfibrozil treatment and high-density lipoprotein subpopulation profile with cardiovascular events in the Veterans Affairs High-Density Lipoprotein Intervention Trial [J].
Asztalos, Bela F. ;
Collins, Dorothea ;
Horvath, Katalin V. ;
Bloomfield, Hanna E. ;
Robins, Sander J. ;
Schaefer, Ernst J. .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2008, 57 (01) :77-83
[6]   Role of LCAT in HDL remodeling: investigation of LCAT deficiency states [J].
Asztalos, Bela F. ;
Schaefer, Ernst J. ;
Horvath, Katalin V. ;
Yamashita, Shizuya ;
Miller, Michael ;
Franceschini, Guido ;
Calabresi, Laura .
JOURNAL OF LIPID RESEARCH, 2007, 48 (03) :592-599
[7]   Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women [J].
Asztalos, Bela F. ;
Swarbrick, Michael M. ;
Schaefer, Ernst J. ;
Dallal, Gerard E. ;
Horvath, Katalin V. ;
Ai, Masumi ;
Stanhope, Kimber L. ;
Austrheim-Smith, Iselin ;
Wolfe, Bruce M. ;
Ali, Mohamed ;
Havel, Peter J. .
JOURNAL OF LIPID RESEARCH, 2010, 51 (08) :2405-2412
[8]   High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study [J].
Asztalos, BF ;
Cupples, LA ;
Demissie, S ;
Horvath, KV ;
Cox, CE ;
Batista, MC ;
Schaefer, EJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (11) :2181-2187
[9]   Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency [J].
Asztalos, BF ;
Horvath, KV ;
Kajinami, K ;
Nartsupha, C ;
Cox, CE ;
Batista, M ;
Schaefer, EJ ;
Inazu, A ;
Mabuchi, H .
JOURNAL OF LIPID RESEARCH, 2004, 45 (03) :448-455
[10]   Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial [J].
Asztalos, BF ;
Collins, D ;
Cupples, LA ;
Demissie, S ;
Horvath, KV ;
Bloomfield, HE ;
Robins, SJ ;
Schaefer, EJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (10) :2185-2191